Our Team

Sanjay Malkani

Sanjay actively advises Executives and drives Boards in middle-market Dx and emerging tech companies. For the decade ending Q1’18, Sanjay served as Global President of the Toxicology division of Alere, Inc (NYSE: ALR), the Global leader in diversified toxicology products, services and rapid diagnostics. Sanjay was a platform consolidator and grew the business from ~$50MM to ~$650MM, deploying ~$1.1B into over 30 merged assets to form a stand-alone division of 2,500+ employees across all major world regions, delivering on significant value creation as measured by a leading Global strategy and Board advisory firm.

As a named executive officer and member of the company’s executive team, he supported Alere’s $5.3 billion sale to Abbott Laboratories, Inc (NYSE: ABT) in 2017.

Sanjay has executive experience across diversified In-Vitro Diagnostics platforms – including Biologics, Point-of-Care Diagnostics, Laboratory Services and Health Information Solutions – and has developed the world-leading business in every healthcare category he has worked in. He held successive executive and commercial leadership positions within the Point-of-Care and Diabetes Care divisions of Roche Diagnostics, Inc. from 2001 to 2008, and within the Specialty Chemicals division of Dow Chemical, Inc.

Sanjay holds an MBA from the Kellogg School at Northwestern University (1998) and an undergraduate degree in Industrial Engineering from Purdue University (1991).